Results 201 to 210 of about 2,926,291 (344)

Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases. [PDF]

J Immunother Cancer
Mandalà M, Chen MF, Sullivan RJ, Sergi MC, Postow M, Lawless AR, Effiom D, Peres T, Lorigan PC, Serra-Bellver P, Dummer R, Amaral T, Rasch ML, Giannarelli D, Vitale MG, Helgadottir H, Robert C, Ubaldi M, Johnson DB, Del Vecchio M, Indini A, Suijkerbuijk KPM, Nathan P, Carter T, Neyns B, Dirven I, Pires da Silva I, Menzies AM, Zimmer L, Livingstone E, Depenni R, Kähler K, Hauschild A, Spagnolo F, Di Giacomo AM, Arance A, Merelli B, Quaglino P, Rossi E, Tucci M, Guida M, Muñoz-Couselo E, Long GV, Larkin J, Ascierto PA.   +44 more
europepmc   +1 more source

Curing brain metastases [PDF]

Clinical & Experimental Metastasis, 2017
openaire   +2 more sources

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source

Bidirectional roles of meningeal lymphatic vessels in brain metastases: friend and foe. [PDF]

Front Oncol
Shao W, Zhu E, Chen D, Lu H.
europepmc   +1 more source

Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine

BMEMat, EarlyView.
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo, Nan Li, Daiwei Zhang, Jingya Gu, Zhihuan Liao, Zihao Teng, Xiangfu Du, Peter S. Timashev, Shipeng Chen, Shuaidong Huo   +9 more
wiley   +1 more source

Brain metastases from colorectal cancer - a retrospective dual center study. [PDF]

J Neurooncol
Müller S, Hendricks A, Uttinger K, Kostatin M, Brüggemann M, Schrader M, Polat B, Flemming S, Lock JF, Germer CT, Wiegering A, Pession U.   +11 more
europepmc   +1 more source

Clinically actionable genomic alterations in breast cancer brain metastases: A Multi-Institutional Retrospective Study

reservedBackground: Le metastasi cerebrali (BMs)rappresentano una complicanza frequente del carcinoma mammario metastatico (BC) e costituiscono una causa significativa di morbidità e mortalità nei pazienti con BC metastatico. Nell’era della medicina di
GUARASCIO, MARIA CRISTINA
core  

Nanomaterials‐mediated glycolysis rewriting to potentiate tumor immunotherapy

BMEMat, EarlyView.
This review systematically summarizes cutting‐edge advances in glycolysis‐rewiring nanomedicines, emphasizing their mechanisms in reversing immunosuppression and reinvigorating antitumor immune responses. Challenges in clinical translation and future directions for designing multifunctional metabolic‐immune modulators are also critically discussed ...
Zilin Ma, Songyan Li, Jie Yan, Xuechun Wang, Wen Zhao, Yunxuan Song, Dongdong Liu, Jianwei Jiao, Xiuying Duan, Guiqiang Zhang   +9 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Dose and clinical impact of delineation variability in brain metastases treated with stereotactic radiotherapy. [PDF]

Clin Transl Radiat Oncol
Perrot A, Dissaux B, Roux AC, Rudzinska-Mistarz S, Marchi L, Lucia F, Seizeur R, Pradier O, Dissaux G, Morjani M, Bourbonne V.   +10 more
europepmc   +1 more source